Clinical Trial Update: Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CVac as maintenance therapy in epithelial ovarian cancer patients in complete remission after first-line or second-line chemotherapy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Cvac

Snippet

Sponsor: Prima BioMed Ltd | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-12-14